{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:43:13Z","timestamp":1775929393646,"version":"3.50.1"},"reference-count":64,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Inappropriate sinus tachycardia (IST) is a rare syndrome characterized by a persistent daytime resting heart rate (HR) &gt;100 beats per minute, a mean 24\u2010h HR of &gt;90 beats per minute, with P wave morphology and axis characteristics similar to that of sinus rhythm. IST is associated with symptomatic palpitation described as an abrupt transient acceleration of HR at rest or minimal activity and is often associated with multiple psychosomatic symptoms.<\/jats:p>\n                  <jats:p>\n                    Self\u2010sustained contractile activity, i.e., pace\u2010making, is the basic physiological process characterizing the sinus node. The funny current (I\n                    <jats:italic>\n                      <jats:sub>f<\/jats:sub>\n                    <\/jats:italic>\n                    ) initially described in sinus node myocytes is a mixed Na\/K cation channel that is slowly activated upon the hyperpolarization of the sinoatrial node's myocytes. This inward current generates repetitive activity responsible for the rhythmic pacemaker activity. The higher the activation of I\n                    <jats:italic>\n                      <jats:sub>f<\/jats:sub>\n                    <\/jats:italic>\n                    current, the steeper will be phase 4 hence greater the frequency of action potential firing, i.e., HR. Dysfunctional funny channels have been identified as playing a critical role in the development of IST, alongside the external influences stemming from modulatory actions of the autonomic nervous and humoral systems. Beta\u2010blockers and calcium channel blockers are current first\u2010line therapies that often require high doses, but are usually inefficient and poorly tolerated.\n                  <\/jats:p>\n                  <jats:p>\n                    Ivabradine has been shown to have unique properties of blocking I\n                    <jats:italic>\n                      <jats:sub>f<\/jats:sub>\n                    <\/jats:italic>\n                    current at low concentration with a use\u2010dependent way, which manifests as a slowly progressing accumulation of the drug during repetitive channel activation\/deactivation cycles. Thus, unlike beta\u2010blockers, Ivabradine, in smaller doses, results in a more substantial blocking effect at higher tachycardic rates and, therefore, more successful in the treatment of IST. The current literature review, which includes a small number of patients, has shown that Ivabradine lowered basal, mean, and maximal HR and was associated with symptomatic improvement. We have described the unique and specific mechanism of action, along with its safety profile, which supports Ivabradine's role as the first\u2010line therapy for the resolution of IST.\n                  <\/jats:p>","DOI":"10.1111\/pace.15214","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:09:01Z","timestamp":1748866141000},"page":"725-732","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should Ivabradine be First\u2010Line Therapy for Inappropriate Sinus Tachycardia?"],"prefix":"10.1111","volume":"48","author":[{"given":"Asif","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Cardiology Northwell New Hyde Park New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3385-3784","authenticated-orcid":false,"given":"Joanne","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Cardiology Northwell New Hyde Park New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valay K.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Cardiology Northwell New Hyde Park New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soad","family":"Bekheit","sequence":"additional","affiliation":[{"name":"Department of Cardiology Northwell New Hyde Park New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.074"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(05)70364-7"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.031"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.03.029"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eupc.2004.12.007"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.00217.x"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000135472.28234.CC"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.019"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2010.02725.x"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X13666171129183826"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13093"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00135-8"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.804369"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.01.005"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767002-00003"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/351145a0"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1997.sp022049"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00236.2007"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-007-0295-2"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.208041"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003070"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.04.009"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2003.03075.x"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2011.02173.x"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16023071"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv582"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2018.090706"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2204139"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.06.011"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.07.041"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus204"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-015-0040-2"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00546-X"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2016.09.014"},{"issue":"14","key":"e_1_2_13_36_1","first-page":"e471","article-title":"2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"133","author":"Page R. L.","year":"2016","journal-title":"Circulation"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464160-00003"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.038"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-015-0066-5"},{"key":"e_1_2_13_40_1","first-page":"56","article-title":"Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients With Heart Failure","volume":"9","author":"Fala L.","year":"2016","journal-title":"American Health & Drug Benefits"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10213"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706940"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.20028593"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753944720934937"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.05.034"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-009-1265-9"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux038"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-010-0565-y"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302795"},{"issue":"2","key":"e_1_2_13_50_1","first-page":"166","article-title":"Efficacy of Ivabradine in Four Patients With Inappropriate Sinus Tachycardia: A Three Month\u2010Long Experience Based on Electrocardiographic, Holter Monitoring, Exercise Tolerance and Quality of Life Assessments","volume":"17","author":"Kaplinsky E.","year":"2010","journal-title":"Journal of Cardiology"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12709"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001203"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03831-6"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab116.114"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.07.004"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2021.11.019"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2020.11.092"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305482"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22578"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.10.004"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200304020-00001"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1159\/000095430"},{"key":"e_1_2_13_64_1","unstructured":"Department of Health and Human Services CfDCaP. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 2018 [updated 2\/14\/2018 https:\/\/www.federalregister.gov\/documents\/2018\/02\/14\/2018\u201002957\/niosh\u2010list\u2010of\u2010antineoplastic\u2010and\u2010other\u2010hazardous\u2010drugs\u2010in\u2010healthcare\u2010settings\u2010proposed\u2010additions\u2010to."},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euy128"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pace.15214","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pace.15214","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pace.15214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:50:22Z","timestamp":1775926222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pace.15214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/pace.15214"],"URL":"https:\/\/doi.org\/10.1111\/pace.15214","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"2025-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}